EuroIntervention PCRonline - Connecting with the community

Gerard C.M. Linssen

8 articles

Three-Year Safety and Efficacy of Treating All-Comers With Newer-Generation Resolute Integrity or Promus Element Stents in the Randomised DUTCH PEERS (TWENTE II) Trial

EuroIntervention 2016; just accepted article published in December 2016

Value of the SYNTAX score for periprocedural myocardial infarction according to WHO and the third universal definition of myocardial infarction: insights from the TWENTE trial

EuroIntervention 2015;12:431-440 published online ahead of print August 2015

Published in Volume 12 Number 4, July 2016

Coronary artery dominance and the risk of adverse clinical events following percutaneous coronary intervention: insights from the prospective, randomised TWENTE trial

EuroIntervention 2015;11:180-187 published online ahead of print February 2014

Published in Volume 11 Number 2, June 2015

Safety of second-generation drug-eluting stents three years after randomised use in the TWENTE trial

EuroIntervention 2015;10:1276-1279 published online ahead of print August 2014

Published in Volume 10 Number 11, March 2015

Clinical outcome following second-generation drug-eluting stent use for off-label versus on-label indications: insights from the two-year outcome of the TWENTE trial

EuroIntervention 2014;10:664-671

Published in Volume 10 Number 6, October 2014

Comparison of eligible non-enrolled patients and the randomised TWENTE trial population treated with Resolute and XIENCE V drug-eluting stents

EuroIntervention 2012;8:664-671

Published in Volume 8 Number 6, October 2012

Absence of a relation between plaque composition in proximal non-target coronary vessels vs. cardiovascular event risk: a pilot study with volumetric radiofrequency-based intravascular ultrasound

Published in Volume 7 Supplement M, May 2011

Periprocedural myocardial infarction following stent implantation: comparison between first and second generation DES

Published in Volume 7 Supplement M, May 2011